INSIGHTS ON PHARMACEUTICAL PRODUCTION

• Leveraging Integrated Electronic Laboratory Notebook And Inventory Systems

  Integrating lab notebooks with inventory and asset tracking boosts accuracy and traceability. Real-time visibility cuts errors, speeds decisions, and supports compliant, scalable pharma development.

• A Collaboration With Fresenius Kabi BioPharm

  Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.

• FDA's New Flexible CMC Framework For CGT

  The FDA is rethinking CMC oversight for cell and gene therapies, prioritizing science‑based justification over rigid validation models. Learn how this lifecycle‑focused approach could reduce burden.

• Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview

  From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.

• Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery

  3/17/2026

  Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.

• Oligonucleotide Synthesis: Scale-Up Made Simple

  10/16/2024

  Scaling oligonucleotide synthesis isn't as straightforward as it seems. Explore key challenges, critical process parameters, and solutions for a smooth scale-up.

• LYO Cycle Development Ensures Success For Oncology Drug Scale-Up

  5/14/2026

  An optimized lyophilization cycle removes excess moisture during scale‑up by adjusting drying for larger equipment, improving stability, maintaining efficiency, and supporting clinical validation.

• Automated PUPSIT For Drug Product Applications

  1/13/2026

  Automated filtration systems streamline PUPSIT, leak testing, and integrity checks to ensure sterile drug product processing. Learn how these methods improve contamination control and compliance.

• CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

  7/8/2025

  Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.